Top-News

Carisma Therapeutics Aktie News

Aktie
WKN:  A3DZG2 ISIN:  US14216R1014 US-Symbol:  CARM Branche:  Biotechnologie Land:  USA
0,05 $
+0,0015 $
+3,09%
0,04294 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
2,16 Mio. €
Streubesitz
55,36%
KGV
-
Index-Zuordnung
-

Carisma Therapeutics News

05.12.25 - PR Newswire
Carisma Announces Delisting from Nasdaq and SEC Deregistration
Carisma Announces Delisting from Nasdaq and SEC Deregistration PR Newswire
16.07.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders PR Newswire
14.07.25 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY PR Newswire
03.07.25 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE PR Newswire
01.07.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, BASE, CARM, ENZB on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, BASE, CARM, ENZB on Behalf of Shareholders PR Newswire
27.06.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders PR Newswire
23.06.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE and CARM on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE and CARM on Behalf of Shareholders PR Newswire
31.03.25 - PR Newswire
Carisma Therapeutics Provides Corporate Updates
Carisma Therapeutics Provides Corporate Updates PR Newswire
19.02.25 - PR Newswire
Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference PR Newswire
05.02.25 - PR Newswire
Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference PR Newswire
09.12.24 - PR Newswire
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
Carisma Therapeutics Announces Strategic Restructuring to Re-​prioritize Pipeline PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »